Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancer

Journal of Controlled Release(2020)10.1016/j.jconrel.2020.04.040Source: DataRank Database

Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancer is a research paper published in Journal of Controlled Release (2020). On theSindex it has a DataRank of 0. It has been cited 57 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access57 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: bronzeTopics (24)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Nasha Qiu ORCID,Limei Shen ORCID,Qi Liu ORCID,Jing Zhang ORCID,Yung‐Yi Cheng

Live enrichment

PubMed:32360890 PMC:PMC8601127

NCI NIH HHS

Grant: U54 CA198999

National Institutes of Health

Grant: 5U54CA198999-04

Nano Approaches to Modulate Host Cell Response for Cancer Therapy

National Institutes of Health

bronzeLicense: Elsevier TDM

https://doi.org/10.1016/j.jconrel.2020.04.040

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601127

https://dx.doi.org/10.17615/3w4b-rf62

https://pubmed.ncbi.nlm.nih.gov/32360890

https://dx.doi.org/10.1016/j.jconrel.2020.04.040

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

T-LymphocytesCell Line, TumorAnimalsHumansMiceImmunotherapyTumor MicroenvironmentTriple Negative Breast Neoplasms

Keywords

Tumor MicroenvironmentTriple Negative Breast CancerImmunogenic Cell Death17-AagHsp90 InhibitorCheckpoint Blockade ImmunotherapyMiceCell Line, TumorT-LymphocytesAnimalsHumansTriple Negative Breast NeoplasmsImmunotherapy

Sustainable Development Goals

SDG 3: 3. Good health